{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:33:22Z","timestamp":1781217202009,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>Sequelae of pelvic inflammatory disease (SPID), such as chronic pelvic pain and infertility, are major long-term complications that significantly harm women\u2019s health. N6-methyladenosine (m6A), the most common internal mRNA modification in eukaryotes, is recognized as a key regulator of gene expression in inflammatory and immune processes, yet its role in SPID pathogenesis remains unclear. This study aimed to investigate the relationships between SPID and m6A methylation of related genes and mRNAs, explore the role of m6A-related mRNAs in SPID, and provide a reference for its clinical application. The discovery of m6A-methylated mRNAs may offer a new perspective for developing therapeutic drugs for SPID. High-throughput sequencing combined with methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing was used to analyze differential m6A methylation and mRNA expression profiles in the peripheral blood of 5 SPID patients and 5 healthy controls. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to explore differentially methylated and expressed mRNAs. Methylated RNA Immunoprecipitation (MeRIP) - Quantitative Real-time Polymerase Chain Reaction (qPCR) and Reverse Transcription (RT)-qPCR were subsequently used to verify the top 3 differentially expressed mRNAs in terms of m6A methylation and mRNA expression levels. Among the significantly differentially methylated genes, 65 were hypermethylated and 140 were demethylated. GO analysis indicated that these genes were primarily involved in mRNA processing, RNA splicing, and neutrophil-mediated immune response. KEGG analysis revealed associations with pathways such as leukocyte transendothelial migration, natural killer cell-mediated cytotoxicity, and the mTOR signaling pathway. RNA-seq results showed 74 upregulated and 116 downregulated genes. GO and KEGG analyses of differentially expressed genes revealed enrichment in the negative regulation of immune system processes and angiogenesis, as well as antigen processing and presentation. Integration of MeRIP-seq and RNA-seq identified 6 genes with significant differences in both m6A modification and mRNA expression, 3 of which were verified by methylated RNA immunoprecipitation (MeRIP)-qPCR and RT-qPCR, with consistent trends with sequencing results. This study established the m6A transcriptional profile in the peripheral blood of SPID patients, revealed potential relationships between mRNA methylation and SPID-related genes, and suggested that m6A modification may be related to the occurrence and progression of SPID.<\/jats:p>","DOI":"10.1097\/md.0000000000046712","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:00:09Z","timestamp":1766203209000},"page":"e46712","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Genome-wide profiling of m6A modification and its role in the transcriptome of sequelae of pelvic inflammatory disease"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2952-2814","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China"},{"name":"Anhui University of Chinese Medicine, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Jiang","sequence":"additional","affiliation":[{"name":"Lunan Pharmaceutical Group Co. Ltd., State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Linyi, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.annemergmed.2015.10.022","article-title":"Improving adolescent pelvic inflammatory disease follow-up from the emergency department: randomized controlled trial with text messages.","volume":"67","author":"Wolff","year":"2016","journal-title":"Ann Emerg Med"},{"issue":"Pt 2","key":"R2-20260522","doi-asserted-by":"crossref","first-page":"119066","DOI":"10.1016\/j.jep.2024.119066","article-title":"New idea of Fuke Qianjin capsule in treating sequelae of pelvic inflammatory disease: anti-inflammatory in the early stage and reparative in the later stage.","volume":"338","author":"Xu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"R3-20260522","first-page":"401","article-title":"Guideline of pelvic inflammatory disease.","volume":"49","author":"Liu","year":"2014","journal-title":"Chung Hua Fu Ch\u02bfan k\u02bfo Tsa Chih"},{"key":"R4-20260522","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015.","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/OLQ.0b013e31821f918c","article-title":"Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.","volume":"38","author":"Trent","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation.","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases.","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tig.2012.11.003","article-title":"Reversible RNA adenosine methylation in biological regulation.","volume":"29","author":"Jia","year":"2013","journal-title":"Trends Genet"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"e105977","DOI":"10.15252\/embj.2020105977","article-title":"m6A RNA methylation: from mechanisms to therapeutic potential.","volume":"40","author":"He","year":"2021","journal-title":"EMBO J"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"2181575","DOI":"10.1080\/15592294.2023.2181575","article-title":"Crosstalk between m6A mRNAs and m6A circRNAs and the time-specific biogenesis of m6A circRNAs after OGD\/R in primary neurons.","volume":"18","author":"Zhang","year":"2023","journal-title":"Epigenetics"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijbiomac.2022.11.042","article-title":"METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","volume":"223","author":"Zhou","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1080\/15548627.2023.2200625","article-title":"NR3C1\/Glucocorticoid receptor activation promotes pancreatic beta-cell autophagy overload in response to glucolipotoxicity.","volume":"19","author":"Wu","year":"2023","journal-title":"Autophagy"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"2190618","DOI":"10.1080\/07853890.2023.2190618","article-title":"RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"2322037","DOI":"10.1080\/0886022X.2024.2322037","article-title":"FTO attenuates TNF-\u03b1-induced damage of proximal tubular epithelial cells in acute pancreatitis-induced acute kidney injury via targeting AQP3 in an N6-methyladenosine-dependent manner.","volume":"46","author":"Li","year":"2024","journal-title":"Ren Fail"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"731365","DOI":"10.3389\/fcell.2021.731365","article-title":"LuHui derivative, a novel compound that inhibits the fat mass and obesity-associated (FTO), alleviates the inflammatory response and injury in hyperlipidemia-induced cardiomyopathy.","volume":"9","author":"Yu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s12276-021-00696-7","article-title":"m6A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p\u2013AQP1\/ANKH axis.","volume":"53","author":"Yang","year":"2021","journal-title":"Exp Mol Med"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12967-023-04209-0","article-title":"METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation.","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jcp.30576","article-title":"N6-methyladenosine RNA methylation: A novel regulator of the development and function of immune cells.","volume":"237","author":"Dong","year":"2022","journal-title":"J Cell Physiol"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology.","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq.","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"R22-20260522","first-page":"2638","article-title":"Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.","volume":"8","author":"Hu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1080\/15384101.2015.1058677","article-title":"Nuf2 is required for chromosome segregation during mouse oocyte meiotic maturation.","volume":"14","author":"Zhang","year":"2015","journal-title":"Cell Cycle"},{"key":"R24-20260522","first-page":"356","article-title":"Correlation analysis of NUF2 gene expression and immune infiltration and clinical prognosis of lung adenocar-cinoma.","volume":"42","author":"Liu","year":"2022","journal-title":"Chin J Hosp Pharm"},{"key":"R25-20260522","first-page":"50","article-title":"Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics.","volume":"60","author":"Li","year":"2022","journal-title":"J Shandong Univ"},{"key":"R26-20260522","first-page":"331","article-title":"To analyze the expression and function of lipid metabolism-related genes in cervical cancer.","volume":"33","author":"Li","year":"2023","journal-title":"Biotechnology"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13048-023-01101-9","article-title":"NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K\/AKT\/mTOR pathway in ovarian cancer.","volume":"16","author":"Ren","year":"2023","journal-title":"J Ovarian Res"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12894-023-01258-x","article-title":"NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Urol"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/j.gastro.2023.01.039","article-title":"TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: implications for colorectal tumors with the CpG island methylator phenotype.","volume":"164","author":"Tricarico","year":"2023","journal-title":"Gastroenterology"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/sj.onc.1208952","article-title":"ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.","volume":"24","author":"Takada","year":"2005","journal-title":"Oncogene"},{"key":"R31-20260522","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ijc.24023","article-title":"Promoter hypermethylation of theADAM23 gene in colorectal cancer cell lines and cancer tissues.","volume":"124","author":"Choi","year":"2009","journal-title":"Int J Cancer"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2613.2011.00766.x","article-title":"The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma.","volume":"92","author":"Hu","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"R33-20260522","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/0008-5472.CAN-08-2976","article-title":"ADAM23 negatively modulates \u03b1v\u03b23 integrin activation during metastasis.","volume":"69","author":"Verbisck","year":"2009","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:00:19Z","timestamp":1779433219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":33,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046712","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}